Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Indiva Temettü

Temettü kriter kontrolleri 0/6

Indiva şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Ödeme oranı

Sektör ortalama getirisi	2.2%
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Hisse başına kazanç	-CA$0.023
Temettü verim tahmini	n/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Indiva Limited's (CVE:NDVA) Subdued P/S Might Signal An Opportunity

May 28

Indiva Limited (CVE:NDVA) Stock Catapults 33% Though Its Price And Business Still Lag The Industry

Sep 29

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: NDVA.H şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: NDVA.H şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Indiva Piyasaya Karşı Temettü Getirisi

NDVA.H temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (NDVA.H)	n/a
Pazarın Alt %25'i (CA)	1.7%
Pazarın En İyi %25'i (CA)	5.8%
Sektör Ortalaması (Pharmaceuticals)	2.2%
Analist tahmini (NDVA.H) (3 yıla kadar)	n/a

Önemli Temettü: NDVA.H şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, NDVA.H şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: NDVA.H şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: NDVA.H herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Indiva Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

Insufficient new directors

Indiva Limited Announces Resignation of Rachel Goldman from the Board

New major risk - Financial position

Indiva Limited's (CVE:NDVA) Subdued P/S Might Signal An Opportunity

Indiva Limited Provides Earnings Guidance for the Second Quarter of 2024

Indiva Limited to Report Q1, 2024 Results on May 23, 2024

Indiva Limited Provides Earnings Guidance for the First Quarter and Fiscal Year 2024

New major risk - Negative shareholders equity

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Indiva Limited to Report Q4, 2023 Results on Apr 25, 2024

New major risk - Market cap size

Insufficient new directors

Indiva Limited announced that it expects to receive CAD 4.312 million in funding

Indiva Limited announced that it expects to receive CAD 4 million in funding

Price target increased by 15% to CA$0.15

Indiva Limited Provides Revenue Guidance for Fourth Quarter of 2023

Third quarter 2023 earnings released: CA$0.005 loss per share (vs CA$0.018 loss in 3Q 2022)

Indiva Limited to Report Q3, 2023 Results on Nov 21, 2023

Indiva Limited (CVE:NDVA) Stock Catapults 33% Though Its Price And Business Still Lag The Industry

Is Indiva (CVE:NDVA) Using Debt In A Risky Way?

Second quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.017 loss in 2Q 2022)

Indiva Limited to Report Q2, 2023 Results on Aug 29, 2023

Indiva Limited Launches No Future Gummies and Vapes

New minor risk - Shareholder dilution

New major risk - Share price stability

Indiva Limited announced that it expects to receive CAD 2.155617 million in funding from Canopy Growth Corporation

Indiva Limited Provides Revenue Guidance for the Second Quarter of 2023

Indiva Limited, Annual General Meeting, Jul 18, 2023

Indiva Limited to Report Q1, 2023 Results on May 16, 2023

Is Indiva (CVE:NDVA) A Risky Investment?

Full year 2022 earnings: EPS and revenues miss analyst expectations

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to CA$0.50

Indiva Limited to Report Q3, 2022 Results on Nov 22, 2022

Indiva Limited Provides Revenue Guidance for the Second Half and Full Year of 2022

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Indiva Limited to Report Q2, 2022 Results on Aug 16, 2022

Indiva Limited Provides Revenue Guidance for the Second Quarter of 2022

Consensus estimates of losses per share improve by 62%

Indiva Limited Provides Revenue Guidance for the Second Quarter of 2022

Indiva Limited to Report Q1, 2022 Results on May 19, 2022

Price target decreased to CA$0.60

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Indiva Limited Provides Net Revenue Guidance for the First Quarter of 2022

Indiva Limited, Annual General Meeting, Jun 23, 2022

Indiva Limited to Report Fiscal Year 2021 Results on Apr 26, 2022

Is Indiva (CVE:NDVA) Using Too Much Debt?

Indiva Limited Launches New Cannabis Edible Designed for MicroDosing

Indiva Launches New Cannabis Edible Formulated for Night-Time Use

Third quarter 2021 earnings released: CA$0.047 loss per share (vs CA$0.035 loss in 3Q 2020)

Would Indiva (CVE:NDVA) Be Better Off With Less Debt?

Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.029 loss in 2Q 2020)

Indiva Limited Provides Revenue Guidance for the Second Half of 2021

First quarter 2021 earnings released: CA$0.025 loss per share (vs CA$0.029 loss in 1Q 2020)

Full year 2020 earnings released: CA$0.16 loss per share (vs CA$0.14 loss in FY 2019)

Indiva Limited to Introduce Two New Bhang Chocolate Flavours Nationally in Second Quarter of 2021

Indiva Limited Ships Wana Quick Gummies

Indiva Limited Appoints Russell Wilson to the Board of Directors

Indiva Limited announced that it has received CAD 11 million in funding from Sundial Growers Inc.

Indiva Announces Extension to License Agreement with Wana Brands Inc

Indiva Limited announced that it expects to receive CAD 11 million in funding from Sundial Growers Inc.

New 90-day high: CA$0.49

New 90-day high: CA$0.28

Independent Director recently bought CA$65k worth of stock

Indiva Limited Promotes Rob Carse to Chief Operating Officer

Price target raised to CA$0.63

Analysts increase revenue estimates to CA$14.9m

Would Indiva (CVE:NDVA) Be Better Off With Less Debt?

Third quarter 2020 earnings released: CA$0.035 loss per share

New 90-day low: CA$0.21

New 90-day low: CA$0.23

Indiva Secures Agreement with Medical Cannabis by Shoppers Inc

Indiva Ships Wana Sour Gummies to Alberta, Saskatchewan, and Yukon Territory

Indiva Ships Wana™ Sour Gummies to British Columbia

Analysts update estimates